T. Rinda Soong

ORCID: 0000-0002-1565-992X · 13 papers in corpus
observational 2026
British journal of cancer ·doi:10.1038/s41416-026-03508-9

BACKGROUND: Non-hormonal intrauterine devices (IUDs) create an inflammatory uterine environment while oral contraceptives (OC) suppress ovulation and have different associations with ovarian cancer risk. We have evaluated the associations o…

observational 2025
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.epi-24-1414

BACKGROUND: Parity and breastfeeding are associated with systemic changes in maternal inflammation and reduced risk of ovarian cancer, but little is known about their impact on the ovarian tumor immune microenvironment. METHODS: We evaluat…

2025
·doi:10.1158/0008-5472.30699610

Supplementary figures and table

observational 2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.07.690

BACKGROUND: Individuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC is predominantly driven by TP53 mutations, but mutations in this gene …

lab-animal 2023
·doi:10.1158/0008-5472.c.6514212.v1

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

lab-animal 2023
·doi:10.1158/0008-5472.c.6514212

AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …

other 2023
JCI insight ·doi:10.1172/jci.insight.164995

Epigenetic aberrations, including posttranslational modifications of core histones, are major contributors to cancer. Here, we define the status of histone H2B monoubiquitylation (H2Bub1) in clear cell ovarian carcinoma (CCOC), low-grade se…

2023
·doi:10.1158/0008-5472.22432671

Supplementary figures and table

2023
·doi:10.1158/0008-5472.22432671.v1

Supplementary figures and table

lab-animal 2022
Cancer research ·doi:10.1158/0008-5472.CAN-22-1294

UNLABELLED: Ovarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem ce…

review 2018
Cancers ·doi:10.3390/cancers10120468

Beginning with the discovery of the BRCA-associated ovarian cancer susceptibility genes and subsequent detailed examination of risk-reducing salpingo-oophorectomy (RRSO) specimens, a new paradigm of ovarian carcinogenesis has unfolded with …

review 2018
Hematology/oncology clinics of North America ·doi:10.1016/j.hoc.2018.07.013

This article summarizes the pathogenesis of ovarian carcinoma, focusing on the paradox of high-grade serous carcinogenesis. The fallopian tube is the prime site of origin in early serous cancers. Because a subset of serous cancers is associ…

review 2018
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.08.005

Given the current lack of effective screening for ovarian cancer, surgical removal of at-risk tissue is the most successful strategy to decrease risk of cancer development. However, the optimal timing of surgery and tissues to remove, as we…